Enhanced Saline-Based Nasal Treatment Composition

Publication ID: 24-11857569_0001_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Saline-Based Nasal Treatment Composition,” Published Technical Disclosure No. 24-11857569_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857569_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,569.

Summary of the Inventive Concept

An improved nasal cleansing composition with optimized pH levels, enhanced gelling properties, and added analgesic and antimicrobial components for better efficacy, comfort, and safety.

Background and Problem Solved

The original saline-based nasal treatment composition had limitations in terms of pH level, gelling properties, and lack of analgesic and antimicrobial components, leading to potential irritation, infection, and discomfort. The new inventive concept addresses these limitations by incorporating a pH-adjusted saline solution, a gelling component that forms a protective barrier, an added analgesic component for rapid pain relief, and an antimicrobial component for reduced contamination risk.

Detailed Description of the Inventive Concept

The enhanced saline-based nasal treatment composition comprises a saline solution with a pH level adjusted to match the natural pH of the nasal cavity, thereby reducing irritation and improving efficacy. The composition also includes a gelling component that forms a protective barrier on the nasal mucosa, reducing the risk of infection. Additionally, an analgesic component is added to provide rapid pain relief, and an antimicrobial component is included to reduce the risk of contamination during use. The surfactant component is optimized to enhance the solubility of the saline solution, improving its ability to remove allergens and debris from the nasal cavity.

Novelty and Inventive Step

The new claims introduce novel features such as pH-adjusted saline solutions, gelling components that form protective barriers, added analgesic components, and antimicrobial components, which are not present in the original patent. These features provide a significant improvement in efficacy, comfort, and safety, making the new inventive concept non-obvious and novel compared to the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the concentration of the analgesic component, using different types of gelling agents, or incorporating additional natural extracts for enhanced soothing properties. Variations could also include different packaging and delivery systems, such as nasal sprays or drops, to cater to different user preferences.

Potential Commercial Applications and Market

The enhanced saline-based nasal treatment composition has significant commercial potential in the healthcare industry, particularly in the nasal care and allergy relief markets. The product could be marketed as a premium, high-efficacy nasal cleansing solution for individuals seeking improved comfort, safety, and relief from nasal congestion and allergies.

Field of Art

Medical device and pharmaceutical compositions, specifically nasal treatment and irrigation technologies, requiring expertise in pharmaceutical formulation, biochemistry, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in pharmaceutical sciences or biomedical engineering, with practical experience in developing topical medical compositions, understanding of mucosal physiology, and knowledge of standard formulation techniques

Obviousness Rationale

A PHOSITA would recognize that the PTD's modifications represent predictable variations of the source patent's fundamental saline nasal treatment composition. The disclosed enhancements like pH adjustment, gelling components, and added functional ingredients are logical extensions of known nasal treatment design principles. These modifications represent standard engineering approaches to improving existing medical compositions through incremental optimization of performance characteristics.

Obvious Combinations & Variations

Source Patent Element
Saline solution base with natural extracts
PTD Variation
pH-adjusted saline solution matching nasal cavity pH
Obviousness Reasoning
Adjusting solution pH is a routine optimization technique for improving biological compatibility, which would be an obvious design choice for a PHOSITA seeking to enhance mucosal interaction
Source Patent Element
Basic saline cleansing composition
PTD Variation
Added gelling component forming protective mucosal barrier
Obviousness Reasoning
Creating protective barriers in topical medical compositions is a known technique for improving treatment efficacy and reducing infection risk, representing a predictable solution
Source Patent Element
Surfactant component for cleansing
PTD Variation
Enhanced surfactant formulation for improved allergen and debris removal
Obviousness Reasoning
Optimizing surfactant properties is a standard approach in pharmaceutical formulation, representing a straightforward engineering improvement with expected results
Source Patent Element
Natural extract components
PTD Variation
Added analgesic and antimicrobial components
Obviousness Reasoning
Incorporating additional functional ingredients is a common strategy for expanding therapeutic capabilities, using known techniques of pharmaceutical composition design
Source Patent Element
Basic saline nasal treatment composition
PTD Variation
Alternative delivery systems like nasal sprays and drops
Obviousness Reasoning
Exploring multiple delivery mechanisms is a routine design variation for medical compositions, representing an obvious extension of existing technological approaches
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857569, a Person Having Ordinary Skill In The Art would find the variations disclosed in the Published Technical Disclosure to represent obvious modifications to the existing saline nasal treatment composition. The incremental improvements in pH adjustment, barrier formation, and functional ingredient enhancement constitute predictable variations that would be readily conceived by a skilled practitioner without requiring inventive insight beyond the scope of ordinary professional capabilities.

Original Patent Information

Patent NumberUS 11,857,569
TitleSaline-based nasal treatment composition
Assignee(s)Joonem LLC